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The application of nanotechnology to the cardiovascular system has increasingly caught
scientists’ attention as a potentially powerful tool for the development of new generation
devices able to interface, repair, or boost the performance of cardiac tissue. Carbon
nanotubes (CNTs) are considered as promising materials for nanomedicine applications in
general and have been recently tested toward excitable cell growth. CNTs are cylindrically
shaped structures made up of rolled-up graphene sheets, with unique electrical,
thermal, and mechanical properties, able to effectively conducting electrical current in
electrochemical interfaces. CNTs-based scaffolds have been recently found to support
the in vitro growth of cardiac cells: in particular, their ability to improve cardiomyocytes
proliferation, maturation, and electrical behavior are making CNTs extremely attractive for
the development and exploitation of interfaces able to impact on cardiac cells physiology
and function.
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INTRODUCTION
The development of innovative materials able to effectively inter-
face biological tissues and to tune and boost their functional per-
formance is an active and heterogeneous field of current research,
and nanotechnological approaches for interfacing excitable cells
are disclosing very promising perspectives (Silva, 2006; Place
et al., 2009; Dvir et al., 2011a,b; Chan et al., 2013; Shin et al.,
2013). In particular, the development of scaffolds for cardiac
tissue engineering based on conductive nanomaterials is raising
growing interest (Chan et al., 2013; Shin et al., 2013); in this sce-
nario, the exploitation of carbon nanotubes (CNTs) technology to
the development of devices able to interface and support cardiac
physiology is emerging as a concrete, exciting perspective. Indeed,
the electrical conductivity of thematerial is an important factor to
design effective scaffolds able to interface to excitable cells (Dvir
et al., 2011b; Chan et al., 2013).
CNTs are emerging as an ideal material to be interfaced with
electrically active tissues as neuronal and cardiac tissues. This
relatively recently discovered class of materials possess high elec-
trical and thermal conductivity, strong mechanical resistance and
elasticity and have demonstrated good biocompatibility in many
biological studies. Moreover it has been shown that the function-
alization of CNT walls can tune their biological properties and
their metabolic fate (Singh et al., 2006; Lacerda et al., 2008a,b).
Based on these motivations several hypothetical biomedical appli-
cations involving CNT technology have been put forward. Among
them, one of the more appealing is in the area of tissue engi-
neering. Thus, in recent years, CNTs have been largely studied
as key components for innovative composite materials in tissue
engineering.
Highly conductive CNTs-based scaffolds are able to support
the growth and to profoundly impact on and boost the func-
tional performance of neuronal excitable cells (Sucapane et al.,
2009; Fabbro et al., 2011; Voge and Stegemann, 2011). On the
contrary, little is known about the impact of CNT-based plat-
forms on muscular cells in general and on cardiomyocytes in
particular. However, recently, the idea of applying this innova-
tive nanomaterial to impact on and tune cardiac performance
emerged: interfacing CNTs-based scaffolds to highly specialized
and terminally differentiated cardiac myocytes might indeed rep-
resent a promising strategy for the development of two- and
three-dimensional nanostructured, transplantable cell-enrichable
tissue implants (Dvir et al., 2011a,b; Chan et al., 2013).
This Mini Review will summarize the current state-of-the-
art of the application of CNTs technology-based scaffolds to
cardiac cells physiology and function in vitro, highlighting any
promising perspective toward functional improvement of cardiac
tissue.
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EFFECT OF CNTs ON MYOCYTES ELECTRICAL BEHAVIOR
The impact of pure CNTs platforms on the electrophysiologi-
cal behavior of developing cardiomyocytes has been character-
ized for the first time by Martinelli et al. (2012). In this study,
defunctionalized highly purified carbon-nanotube scaffolds were
used as substrates to culture neonatal rat ventricular myocytes
(NRVMs); after 2–3 days in culture, the electrical properties
of single myocytes, still not fused to form multinucleated syn-
cytia, were analyzed by the patch clamp technique. NRVMs
grown on CNTs layers showed more negative values of rest-
ing membrane potential than controls (i.e., NRVMs grown on
gelatin substrates), while other passive membrane properties,
such as cell capacitance and input resistance, were comparable
in cells developed on CNTs or gelatin. Similarly, multinucle-
ated cells able to contract and originating from the fusion of
many single NRVMs exhibited a more negative resting poten-
tial when grown on CNTs layer compared to controls, with no
effect on other basic properties (capacitance and input resistance;
Martinelli et al., 2013). The same study also investigated active
electrical properties of cardiomyocytes and revealed that CNTs
substrates increase the fraction of NRVMs able to fire action
potentials, while preserving action potentials kinetic and firing
frequency (Martinelli et al., 2012). The impact of CNTs on car-
diomyocytes electrical activity patterns was further investigated
by calcium imaging experiments, to monitor the appearance of
action potential-independent spontaneous calcium transients in
NRVMs. In both controls and CNTs-interfaced cultures, intra-
cellular calcium oscillatory behavior was pretty heterogeneous.
However, NRVMs showing either only sporadic and isolated
events, or clusters of slow frequency events, or clusters of fast
events could be distinguished. When cultures were grown on
CNTs, a larger fraction of cells exhibiting sporadic events com-
pared to controls emerged, confirming that interfacing to CNTs
promotes a more rapid NRVMs maturation (Martinelli et al.,
2013).
The more hyperpolarized resting potential detected in both
single NRVM and multinucleated syncytia, and the higher per-
centage of cells able to fire action potential and showing sporadic
calciumoscillations indicate that the process ofmaturation of car-
diac cells is accelerated by CNTs, while such properties are kept in
a physiological range. However, the mechanisms underlying this
accelerated development have not been clarified yet, although the
tight physical interactions between cellular membrane and CNTs,
revealed by electron microscope analyses, are likely to play a key
role (Martinelli et al., 2012, 2013; Figure 1). In this respect, it is
interesting to note that these cardiomyocytes/CNTs hybrids are
very similar to what has been observed for other excitable cells
(neurons) grown on CNTs supports (Cellot et al., 2009), thus,
indicating an intrinsic CNTs ability to intimately interact with
excitable cells membranes.
The unique properties of CNTs as interfaces for cardiac tissue
growth has been recently implemented by integrating conven-
tional scaffolds materials with CNTs, to create high-performance
hybrid scaffolds. Shin et al. (2013) reported the use of a new
scaffold (CNT-GelMA) composed of CNTs homogenously incor-
porated into gelatin methacrylate (GelMA): the two compo-
nents together form a biocompatible, mechanically strong, and
FIGURE 1 | Cardiomyocytes intimately hybridize with CNTs substrates.
(A) Scanning electron micrograph showing the close interactions between
the membrane of a cultured cardiomyocyte and the CNTs growth substrate.
Reprinted with permission from Martinelli et al. (2013). (B) Scanning
electron micrographs of myocytes (in false color) cultured on
randomly-oriented CNTs (a–c) or on vertically-aligned CNTs (d–f). On the
vertically aligned substrate, single CNTs cross the membrane and
penetrate into the intracellular space. Reprinted with permission from Fung
et al. (2010).
electrically conductive structure. Neonatal cardiomyocytes were
cultured for several days on such scaffold; interestingly, cells
grown on CNT-GelMA are characterized by a more stable spon-
taneous beating behavior, with a beating rate significantly higher
than that of cells grown on GelMA alone. Moreover, the car-
diac tissue appears more mechanically strong and intact on
CNT-GelMA than on GelMA alone, probably because of a bet-
ter tissue anchoring to the CNT-reinforced scaffold structure, as
indicated by the physical contacts between cell membranes and
carbon nanotube-nanofibers observed by electron microscopy.
Importantly, CNT-GelMA scaffold seems to exert also a protec-
tive effect for host cells. Indeed, treatment with heptanol, able
to quickly alter the physiological beating in control cells acting
on gap junctions, has only a delayed, attenuated effect on car-
diac tissue cultured on CNT-GelMA. This finding suggests that
CNTs might promote the electrical communication between car-
diac cells possibly beyond gap junctions’ efficacy (Shin et al.,
2013).
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IMPACT OF CNTs SCAFFOLDS ON MYOCYTES
MORPHOLOGY, PROLIFERATION, AND MATURATION
The boost toward a functionally and electrically more mature
phenotype induced by CNTs-based scaffolds is likely to be related
to a general impact of CNTs substrates on cardiomyocyte growth,
including a modulation of their morphology and proliferative
ability. Recently, Martinelli et al. (2012) demonstrated the ability
of pure multi-walled carbon nanotube scaffolds to promote cel-
lular viability, myocyte proliferation, and maturation in NRVMs,
compared to control. In this study, metabolic activity assays,
bromodeoxyuridine (BrdU) incorporation, flow cytometry and
cell division markers demonstrated that CNTs not only support
cardiomyocytes viability, but also selectively influence NRVM
proliferating ability, with a doubling in cell number after 3 days
culturing. Importantly, CNTs impact on cell proliferation was
selective for cardiomyocytes, as fibroblast viability and prolif-
eration were unchanged. Furthermore, CNTs growth substrates
ability to promote cardiomyocytes proliferation is significantly
higher compared to other growth-permissive substrates [indium
tin oxide—ITO-glass, gelatin-coated ITO-glass, amorphous car-
bon coated glass, and poly (D,L-lactide-co-glycolide)—PLGA-]
(Martinelli et al., 2012).
Similarly, Meng et al. (2013) showed that human cardiomy-
ocytes improve their adhesion and proliferation when cultured
on a composite of carbon nanofibers and poly-2-hydroxyethyl
methacrylate (pHEMA, a biocompatible hydrogel) compared to
pHEMA alone or tissue culture polystyrene, an effect strictly
dependent on carbon nanofibers concentration (Meng et al.,
2013).
In addition to cardiomyocytes proliferative ability, CNTs plat-
forms also have a profound effect on cardiomyocytes gene pro-
gram and syncytia development. This ability has been recently
characterized by Martinelli et al. (2013), by studying the
expression of five key genes involved in the growth/fetal gene
expression program: cardiac beta-myosin heavy chain (βMHC),
alpha-myosin heavy chain (αMHC), A-type Natriuretic Peptide
(ANP), sarcoplasmic reticulum Ca2+ ATPase2a (SERCA2a) and
skeletal-Actin (Sk-Actin). Genes associated to amoremature phe-
notype like αMHC are significantly increased in cardiomyocytes
grown on CNTs compared to gelatin controls after 3 days cul-
turing, while at the same time, the levels of pathological cardiac
hypertrophy markers (βMHC and Sk-Actin) were unaffected.
Therefore, after an initial pro-proliferative profile, CNTs scaf-
folds promote a “mature gene expression profile” of cardiomy-
ocytes over time (Martinelli et al., 2012, 2013). Importantly, the
amount of gap-junctions (revealed by Connexin43 immunos-
taining; Figure 2) was significantly higher on CNTs than on
control substrate, in agreement with the significant increase in
gap junctions in syncytia-beating domains (Martinelli et al., 2012,
2013).
Pure CNTs growth supports also show another very inter-
esting and unique property, i.e., their protective activity against
cardiomyocytes hypertrophy, induced by the G-protein-coupled
receptor ligand phenylephrine (Martinelli et al., 2013). These
findings further emphasize the potential of CNTs for a vari-
ety of therapeutic applications in heart diseases, including tissue
engineering and stem cells-based therapies.
In tissue engineering, the search for new biomechanical sup-
ports for cell growth to promote the development of functional
tissue is a subject of extraordinarily intense research activity, and
many groups have introduced novel strategies to study cell adhe-
sion, viability, proliferation and organization on highly porous
two- and three-dimensional scaffolds (Langer and Vacanti, 1993;
Dvir et al., 2011a,b; Chan et al., 2013; Shin et al., 2013). In
this context, CNTs have attracted tremendous attention: indeed,
significant advancements have been recently achieved by the
excellent mechanical integrity and advanced electrophysiologi-
cal functions of the CNTs-based cardiac constructs developed
by Shin et al. (2013; see above). Their CNT-GelMA hydro-
gel indeed strongly improves adhesion, viability, proliferation,
FIGURE 2 | Increased expression of gap junctions in cardiomyocytes
grown on CNTs scaffolds. (A) Neonatal cardiomyocytes grown on
CNTs (MWCNT, left) or on control gelatin substrate (right) stained for
connexin 43 (red), sarcomeric Alpha-Actinin (green), and counterstained
with DAPI (blue). Bars: 50μm. (B) The expression of connexin 43
(gap-junctions) after 1, 2, and 3 days culturing is increased in cultures
grown on the CNTs scaffold. Reprinted with permission from Martinelli
et al. (2013). ∗∗p < 0.01; ∗∗∗p < 0.001.
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and organization of the engineered cardiac tissue compared to
control GelMA hydrogel films. On CNT-GelMA cardiomyocytes
are homogeneously distributed and better interconnected, cov-
ering the entire CNT-GelMA surface with a strong increase in
cell adhesion and elongation, spreading, retention and viability
compared to GelMA controls. The 2D cardiac tissue cultured
on CNT-GelMA also displays better defined and elongated sar-
comeric structures with partial uniaxial alignment, with an
up-regulation of the cardiac specific markers Sarcomeric α-
Actinin and Troponin I (with only a moderate Cx-43 expression).
Importantly, similarly to pure CNTs scaffolds (Martinelli et al.,
2012), CNT-GelMA substrates do not alter cardiac fibroblasts
proliferation (Shin et al., 2013).
It is important to note that, in addition to cardiac myocytes,
the biocompatibility and impact of CNTs scaffolds on cellular
growth and differentiation have been also demonstrated for non-
cardiac muscle cells. CNT-GelMA, in fact, is also able to support
the growth of C2C12 skeletal myoblasts (Tsukahara and Haniu,
2011). Ramón-Azcón et al. (2013) exploited dielectrophoresis
(electric field application to induce molecules charge polariza-
tion) to pattern CNTs into GelMA hydrogels. Thanks to this
approach, the authors were able to generate CNT-GelMA scaf-
folds in which the nanomaterial is highly aligned, a property
conferring better conductivity to the scaffold. Skeletal myoblasts
grown on these substrates showed a marked alignment and
boosted expression of myogenin, MRF4, sarcomeric actin, α-
Actinin and myosin heavy chain isofactor IId/x compared to cells
grown on GelMa hydrogel with dispersed CNTs, i.e., a more
mature profile of contracting cells. Similarly, Holt and cowork-
ers (2013) observed that highly aligned CNTs encourage the
growth of mouse precursor skeletal muscle cells along a preferred
direction.
McKeon-Fischer et al. (2011) showed that, when cul-
tured on an acid-functionalized multi-walled carbon nan-
otube/polycaprolactone electrospun scaffold (PLC-MWCNT-H),
primary skeletal muscle cells display an increased ability to
form large multinucleated constructs with increased actin fila-
ments interaction compared to polycaprolactone scaffolds alone.
Furthermore, MacDonald et al. (2005) showed that collagen-
CNTs constructs support smooth muscle fibers growth. CNTs
are therefore a versatile and effective material to implement and
strengthen the biological activity of a variety of composite tissue
scaffolds for the growth and functional differentiation of various
muscular cell types.
In addition to CNTs-based growth-supporting scaffolds, the
impact of the application of CNTs in the form of suspension in
the culture medium on muscular (including cardiac) cells sur-
vival and growth has been investigated. In 2006, Garibaldi and
colleagues exposed cardiacmuscle cells from the H9c2 (2-1) heart
cell line to pure single-walled nanotubes suspended in culture
medium, and observed no short-term toxicity of soluble CNTs
(limited proliferative ability and morphological changes were
identified only after CNTs-treated cells reseeding; Garibaldi et al.,
2006). Recently, Lin et al. (2012) reported that dispersed suspen-
sion of pure single-walled CNTs in the culture medium promotes
vascular adventitial fibroblasts transformation into myofibrob-
lasts, with an up-regulation of the SM22−α differentiation marker
expression, although accompanied by an increased oxydative
damage (Lin et al., 2012). It has to be noted, however, that
pure (non-functionalized) CNTs are a water-insoluble, aggregate-
forming material, and the presence of CNTs aggregates is related
to decreased cell viability, at least for smooth muscle cells (Raja
et al., 2007).
CNTs FOR CARDIAC CELLS ELECTRICAL INTERFACING
In addition to their use as cell-instructive and growth-supporting
conductive scaffolds, the unique CNTs electrical properties sug-
gested their exploitation for the development of innovative nano-
engineered devices to both stimulate and record electrical activity
from electrically active cells such as muscular ones, improving
signal-to-noise ratio, and causing minimal cell damage, simi-
larly to what has been shown for neuronal CNTs-based inter-
faces (Fabbro et al., 2011; Bareket-Keren and Hanein, 2012).
In 2010, Fung and colleagues interfaced NRVMs to microfabri-
cated arrays of CNT microelectrodes: in addition to an extremely
low electrode impedance of both pristine and O2 plasma-treated
CNTs microelectrodes, the authors showed that the interaction of
NRVMs membrane with the electrodes strictly depends on CNTs
orientation: while vertically-aligned nanotubes penetrate NRVMs
membrane, randomly oriented ones remain external to the cells,
suggesting CNTs microelectrodes as effective tools to strongly
improve nano/bio interfaces (Figure 1). Accordingly, Nick et al.
(2012) reported the use of an array of multiple multielectrodes
covered by CNTs, where chicken embryonic cardiomyocytes were
cultured and their electrical activity monitored. Cardiomyocyes
grew well on CNTs-integrated arrays, forming a dense cellular
network and starting to contract after about 36 h from plating.
Recordings made by CNTs-covered electrodes were characterized
by a lower noise level and a better signal resolution compared
to recordings obtained by standard gold or titanium electrodes
(Nick et al., 2012). Similarly, multielectrode arrays can be cov-
ered by a CNTs and poly (3,4-ethylenedioxythiophene) (PEDOT,
a conductive polymer) composite (Gerwig et al., 2012). In this
work, primary embryonic cardiomyocytes were cultured for up
to 10 days on PEDOT alone or on PEDOT-CNTs microelec-
trodes. Cells in both culturing conditions displayed excellent
viability and functionality, as they started to contract 2–3 days
after plating and formed a two dimensional syncytium on both
PEDOT and PEDOT-CNTs microelectrode arrays. Also in this
case CNTs enhanced the electrodes performance, as PEDOT-
CNTs microarrays have higher capacitance and charge injection
capacity than electrodes covered by PEDOT alone, while both
type ofmicroarrays are effective in showing higher signal-to-noise
ratio compared to titanium electrodes (Gerwig et al., 2012).
A very interesting application of the above reported CNTs-
based growth scaffolds is the possibility of eliciting contrac-
tions of the cultured cardiac tissue by applying an elec-
tric field to the growth scaffold itself. Indeed, thanks to
their excellent conductive properties, when CNTs are inte-
grated in the growth scaffold structure the intensity of
the electrical field necessary to elicit contraction is hugely
reduced compared to non-CNTs-containing scaffolds (as in
the case of CNT-GelMA composites: Shin et al., 2013). This
property is extremely important in the perspective of employing
CNTs-based devices for cardiac tissue stimulation purposes
in vivo, as it preserves cardiac cells from the damage induced
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by the pH and gas environment alterations possibly produced in
the ionic solution by the electrical stimulation itself (Shin et al.,
2013).
Electrical stimulations delivered through the CNTs-containing
scaffolds can also be exploited to control and tune the maturation
of both cardiac and skeletal muscular cells. Mooney et al. (2012)
observed that the electrical stimulation of human mesenchi-
mal stem cells (MSCs)cultured on a poly-L-lactide acid (PLA)-
CNT scaffold show a more elongated morphology compared to
unstimulated MSCs. Electrical stimulation also impacts on CNTs-
exposed MSC differentiation toward a cardiomyocyte lineage, as
it modulated the expression of the cardiac marker CMHC (car-
diac myosin heavy chain; Mooney et al., 2012). Interestingly,
the electrical stimulation of MSCs exposed to soluble COOH-
functionalized CNTs pushes their differentiation toward a cardiac
lineage, as the treatment induced a strong up-regulation of the
cardiac markers NKx2.5, GATA-4 and CTT (Mooney et al., 2012).
The combination of CNTs-based scaffolds and electrical stim-
ulation has been applied also to skeletal muscle cells. Sirivisoot
and Harrison (2011) reported that skeletal myotubes cultures
grown on a polyurethane-CNTs composite scaffold and electri-
cally stimulated through the scaffold itself, show a higher number
and length of cells compared to cultures grown without electrical
stimulation. Furthermore, in the presence of electrical stimu-
lation, myotube formation increased in the polyurethane-CNTs
composite compared to polyurethane alone.
REMARKS AND CONCLUSIONS
CNTs intimately interact with cardiomyocytes membranes, a
property allowing a strong improvement of the electrophysio-
logical recordings obtained through CNTs-based devices. On the
other hand, scaffolds based on this nanomaterial (pure or mixed
with biocompatible polymers) can boost, within a physiological
range, cardiac cells maturation, while supporting and promot-
ing cellular viability and adhesion, stimulating a pro-proliferative
program and promoting cell differentiation. Furthermore, CNTs
scaffolds are able to exert a protective role for cardiomyocytes
against pathological stimuli (like pathological hypertrophy). All
these properties make CNTs excellent candidates for the develop-
ment of innovative, effective, and performing devices to interface
and engineer cardiac tissue, with the added value of the intrinsic
electric conductivity of the scaffold itself. The promising exploita-
tion of CNTs-based platforms for cardiac applications is further
encouraged by the growing amount of data on CNTs biocompat-
ibility and impact on immune responses. Serious concerns have
been raised about CNTs safety as toxic effects were reported after
CNTs injection in lungs (Poland et al., 2008). CNTs toxicity is,
however, related to the presence of impurities (Vittorio et al.,
2008) and to CNTs geometry and functionalization (Sayes et al.,
2006; Bianco et al., 2011; Al-Jamal et al., 2012). Appropriately
functionalized CNTs do not impact on B and T lymphocytes and
macrophages viability (Dumortier et al., 2006). Subcutaneously
applied oxidized MWCNTs induce complement activation and
proinflammatory cytokines production which disappear over
time, with only minor inflammatory reactions at the injection
sites (Meng et al., 2011). Furthermore, implanted devices based
on immobilized CNTs induce only minimal local foreign-body
responses (Nayagam et al., 2011). Appropriate CNTs manipu-
lation can thus powerfully decrease or eliminate their potential
adverse effects and increase their safety of use.
ACKNOWLEDGMENTS
Financial support from ERC Advanced Grant Carbonanobridge
(ERC-2008-AdG-227135).
REFERENCES
Al-Jamal, K. T., Nunes, A., Methven,
L., Ali-Boucetta, H., Li, S., Toma,
F. M., et al. (2012). Degree of
chemical functionalization of CNTs
determines tissue distribution and
excretion profile. Angew. Chem.
Int. Ed. Engl. 51, 6389–6393. doi:
10.1002/anie.201201991
Bareket-Keren, L., and Hanein, Y.
(2012). Carbon nanotube-based
multi electrode arrays for neuronal
interfacing: progress and prospects.
Front. Neural Circuits 6:122. doi:
10.3389/fncir.2012.00122
Bianco, A., Kostarelos, K., and
Prato, M. (2011). Making CNTs
biocompatible and biodegrad-
able. Chem. Commun. 47,
10182–10188. doi: 10.1039/c1cc1
3011k
Cellot, G., Cilia, E., Cipollone, S.,
Rancic, V., Sucapane, A., Giordani,
S., et al. (2009). CNTs might
improve neuronal performance
by favouring electrical shortcut.
Nat. Nanotechnol. 4, 126–133. doi:
10.1038/nnano.2008.374
Chan, V., Raman, R., Cvetkovic, C.,
and Bashir, R. (2013). Enabling
Microscale and Nanoscale
Approaches for Bioengineered
Cardiac Tissue. ACS Nano 7,
1830–1837. doi: 10.1021/nn401098c
Dumortier, H., Lacotte, S., Pastorin, G.,
Marega, R., Wu, W., Bonifazi, D.,
et al. (2006). Functionalized carbon
nanotubes are non-cytotoxic and
preserve the functionality of pri-
mary immune cells. Nano Lett. 6,
1522–1528. doi: 10.1021/nl061160x
Dvir, T., Timko, B. P., Brigham, M.
D., Naik, S. R., Karajanagi, S. S.,
Levy, O., et al. (2011a). Nanowired
three dimensional cardiac patches.
Nat. Nanotechnol. 6, 720–725. doi:
10.1038/nnano.2011.160
Dvir, T., Timko, B. P., and Langer, R.
(2011b). Nanotechnological strate-
gies for engineering complex tis-
sues. Nat. Nanotechnol. 6, 13–22.
doi: 10.1038/nnano.2010.246
Fabbro, A., Toma, F. M., Cellot, G.,
Prato, M., and Ballerini, L. (2011).
“CNTs and neuronal performance,”
in Nanomedicine and the Nervous
System, eds C. R. Martin, V. R.
Preedy, and R. J. Hunter (Enfield,
NH: Science Publishers, CRC Press-
Taylor and Francis), 183–208. ISBN
978-1-5780-8728-0.
Fung, A. O., Tsiokos, C., Paydar, O.,
Chen, L. H., Jin, S., Wang, Y.,
et al. (2010). Electrochemical prop-
erties and myocyte interaction of
carbon nanotube microelectrodes.
Nano Lett. 10, 4321–4327. doi:
10.1021/nl1013986
Garibaldi, S., Brunelli, C., Bavastrello,
V., Ghigliotti, G., and Nicolini,
C. (2006). Carbon nanotube
biocompatibility with cardiac
muscle cells. Nanotechnology 17,
391–397. doi: 10.1088/0957-4484/
17/2/008
Gerwig, R., Fuchsberger, K.,
Schroeppel, B., Link, G. S.,
Heusel, G., Kraushaar, U., et al.
(2012). PEDOT-CNT composite
microelectrodes for recording and
electrostimulation applications:
fabrication, morphology, and elec-
trical properties. Front. Neuroeng.
5:8. doi: 10.3389/fneng.2012.00008
Holt, I., Gestmann, I., and Wright, A.
C. (2013). Alignment of muscle pre-
cursor cells on the vertical edges
of thick carbon nanotube films.
Mater. Sci. Eng. C Mater. Biol. Appl.
33, 4274–4279. doi: 10.1016/j.msec.
2013.06.017
Lacerda, L., Ali-Boucetta, H., Herrero,
M. A., Pastorin, G., Bianco,
A., Prato, M., et al. (2008a).
Tissue histology and physi-
ology following intravenous
ad-ministration of different types
of functionalized multiwalled car-
bon nanotubes. Nanomedicine 3,
149–161. doi: 10.2217/17435889.3.
2.149
Lacerda, L., Herrero, M. A., Venner,
K., Bianco, A., Prato, M.,
and Kostarelos, K. (2008b).
Car-bon-nanotube shape and
individualization critical for renal
excretion. Small 4, 1130–1132. doi:
10.1002/smll.200800323
Langer, R., and Vacanti, J. P. (1993).
Tissue engineering. Science 260,
920–926. doi: 10.1126/science.
8493529
www.frontiersin.org September 2013 | Volume 4 | Article 239 | 5
Martinelli et al. CNTs and cardiac myocytes
Lin, Z., Liu, L., Xi, Z., Huang, J.,
and Lin, B. (2012). Single-walled
CNTs promote rat vascular adven-
titial fibroblasts to transform into
myofibroblasts by SM22-α expres-
sion. Int. J. Nanomed. 7, 4199–4206.
doi: 10.2147/IJN.S34663
MacDonald, R. A., Laurenzi, B. F.,
Viswanathan, G., Ajayan, P. M.,
and Stegemann, J. P. (2005).
Collagen–carbon nanotube com-
posite materials as scaffolds in
tissue engineering. J. Biomed. Mat.
Res. A 74, 489–496. doi: 10.1002/
jbm.a.30386
Martinelli, V., Cellot, G., Toma, F.
M., Long, C. S., Caldwell, J. H.,
Zentilin, L., et al. (2012). CNTs pro-
mote growth and spontaneous elec-
trical activity in cultured cardiac
myocytes.Nano Lett. 12, 1831–1838.
doi: 10.1021/nl204064s
Martinelli, V., Cellot, G., Toma, F.
M., Long, C. S., Caldwell, J. H.,
Zentilin, L., et al. (2013). CNTs
instruct physiological growth
and functionally mature syncytia:
nongenetic engineering of cardiac
myocytes. ACS Nano 7, 5746–5756.
doi: 10.1021/nn4002193
McKeon-Fischer, K. D., Flagg, D. H.,
and Freeman, J. W. (2011). Coaxial
electrospunpoly (ε-caprolactone),
multiwalled CNTs, and polyacrylic
acid/polyvinyl alcohol scaffold for
skeletal muscle tissue engineer-
ing. J. Biomed. Mat. Res. A 99,
493–499. doi: 10.1002/jbm.a.33116
Meng, J., Yang, M., Jia, F., Xu, Z., Kong,
H., and Xu, H. (2011). Immune
responses of BALB/c mice to sub-
cutaneously injected multi-walled
carbon nanotubes. Nanotoxicology
5, 583–591. doi: 10.3109/17435390.
2010.523483
Meng, X., Stout, D. A., Sun, L.,
Beingessner, R. L., Fenniri, H.,
and Webster, T. J. (2013). Novel
injectable biomimetic hydrogels
with carbon nanofibers and self
assembled rosette nanotubes for
myocardial applications. J. Biomed.
Mater. Res. A 101, 1095–1102. doi:
10.1002/jbm.a.34400
Mooney, E., Mackle, J. N., Blond, D.
J.-P., O’Cearbhaill, E., Shawa, G.,
Blau, W. J., et al. (2012). The elec-
trical stimulation of CNTs to pro-
vide a cardiomimetic cue to MSCs.
Biomaterials 33, 6132–6139. doi:
10.1016/j.biomaterials.2012.05.032
Nayagam, D. A., Williams, R. A., Chen,
J., Magee, K. A., Irwin, J., Tan, J.,
et al. (2011). Biocompatibility of
immobilized aligned carbon nan-
otubes. Small 7, 1035–1042. doi:
10.1002/smll.201002083
Nick, C., Joshi, R., Schneider, J. J.,
and Thielemann, C. (2012). Three-
dimensional carbon nanotube elec-
trodes for extracellular recording of
cardiac myocytes. Biointerphases 7,
58. doi: 10.1007/s13758-012-0058-2
Place, E. S., Evans, N. D., and Stevens,
M. M. (2009). Complexity in
biomaterials for tissue engineer-
ing. Nat. Mater. 8, 457–470. doi:
10.1038/nmat2441
Poland, C. A., Duffin, R., Kinloch, I.,
Maynard, A., Wallace, W. A., Seaton,
A., et al. (2008). Carbon nan-
otubes introduced into the abdom-
inal cavity of mice show asbestos-
like pathogenicity in a pilot study.
Nat. Nanotechnol. 3, 423–428. doi:
10.1038/nnano.2008.111
Raja, P. M. V., Connolley, J., Ganesan,
G. P., Ci, L., Ajayan, P. M.,
Nalamasu, O., et al. (2007). Impact
of carbon nanotube exposure,
dosage and aggregation on smooth
muscle cells. Toxicol. Lett. 169,
51–63. doi: 10.1016/j.toxlet.2006.
12.003
Ramón-Azcón, J., Ahadian, S., Estili,
M., Liang, X., Ostrovidov,
S., Kaji, H., et al. (2013).
Dielectrophoretically aligned
carbon nanotubes to control
electrical and mechanical properties
of hydrogels to fabricate contractile
muscle myofibers. Adv. Mater. 25,
4028–4034. doi: 10.1002/adma.2013
01300
Sayes, C. M., Liang, F., Hudson, J.
L., Mendez, J., Guo, W., Beach, J.
M., et al. (2006). Functionalization
density dependence of SWNT cyto-
toxicity in vitro. Toxicol. Lett. 161,
135–142. doi: 10.1016/j.toxlet.2005.
08.011
Shin, S. R., Jung, S. M., Zalabany, M.,
Kim, K., Zorlutuna, P., Kim, S. B.,
et al. (2013). Carbon-Nanotube-
Embedded Hydrogel Sheets for
Engineering Cardiac Constructs
and Bioactuators. ACS Nano 7,
2369–2380. doi: 10.1021/nn305559j
Silva, G. A. (2006). Neuroscience
nanotechnology: progress, oppor-
tunities and challenges. Nat. Rev.
Neurosci. 7, 65–74. doi: 10.1038/
nrn1827
Singh, R., Pantarotto, D., Lacerda, L.,
Pastorin, G., Klumpp, C., Prato, M.,
et al. (2006). Tissue biodistribu-
tion and blood clearance rates of
intravenously administered carbon
nanotube radiotracers. Proc. Natl.
Acad. Sci. U.S.A. 103, 3357–3362.
doi: 10.1073/pnas.0509009103
Sirivisoot, S., and Harrison, B. S.
(2011). Skeletal myotube forma-
tion enhanced by electrospun
polyurethane carbon nanotube
scaffolds. Int. J. Nanomedicine
6, 2483–2497. doi: 10.2147/IJN.
S24073
Sucapane, A., Cellot, G., Prato,
M., Giugliano, M., Parpura,
V., and Ballerini, L. (2009).
Interactions Between Cultured
Neurons and Carbon Nanotubes:
A Nanoneuroscience Vignette.
J. Nanoneurosci. 1, 10–16. doi:
10.1166/jns.2009.002
Tsukahara, T., and Haniu, H. (2011).
Nanoparticle-mediated intracel-
lular lipid accumulation during
C2C12 cell differentiation. Biochem.
Biophys. Res. Commun. 406,
558–563. doi: 10.1016/j.bbrc.2011.
02.090
Vittorio, O., Raffa, V., and Cuschieri,
A. (2008). Influence of purity and
surface oxidation on cytotoxicity
of multiwalled carbon nanotubes
with human neuroblastoma cells.
Nanomedicine 5, 424–431. doi:
10.1016/j.nano.2009.02.006
Voge, C. M., and Stegemann, J. P.
(2011). CNTs in neural interfac-
ing applications. J. Neural Eng.
8:011001. doi: 10.1088/1741-2560/
8/1/011001
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 26 July 2013; accepted: 14
August 2013; published online: 03
September 2013.
Citation: Martinelli V, Cellot G, Fabbro
A, Bosi S, Mestroni L and Ballerini
L (2013) Improving cardiac myocytes
performance by carbon nanotubes
platforms†. Front. Physiol. 4:239. doi:
10.3389/fphys.2013.00239
This article was submitted to Cardiac
Electrophysiology, a section of the journal
Frontiers in Physiology.
Copyright © 2013 Martinelli, Cellot,
Fabbro, Bosi, Mestroni and Ballerini.
This is an open-access article dis-
tributed under the terms of the Creative
Commons Attribution License (CC BY).
The use, distribution or reproduction
in other forums is permitted, provided
the original author(s) or licensor are
credited and that the original publica-
tion in this journal is cited, in accor-
dance with accepted academic practice.
No use, distribution or reproduction is
permitted which does not comply with
these terms.
Frontiers in Physiology | Cardiac Electrophysiology September 2013 | Volume 4 | Article 239 | 6
